Geneva workshop on ACTA, June 28, 2010

On June 28, 2010, Knowledge Ecology International (KEI) and IQsensato are co-hosting a workshop on the Anti-Counterfeiting Trade Agreement (ACTA).

The Location of the meeting is the Maison des Associations, on Rue des Savoises 15, Geneva, in the Salle Gandhi.

Speakers

  • Carlos Correa, University of Buenos Aires
  • Erik Josefsson, Adviser, Greens/EFA-European Parliament
  • James Love, Knowledge Ecology International (KEI)
  • Continue Reading

Uncategorized
1

How Much Time is Necessary to Negotiate the Text of a Multilateral Agreement on Intellectual Property?

There is a negotiation in the WIPO SCCR over the work program on copyright limitations and exceptions for persons with disabilities. Some countries favor a negotiation on a binding treaty. The US government is asking that the SCCR set aside work on the treaty, and focus instead on a non-binding recommendation to address a limited set of issues relating to the import and export of works created under an exception. The US government asserts that treaties would take a very long time to negotiate, ratify and implement. Continue Reading

Uncategorized

ACTA to cover seven catagories of intellectual property

KEI has access to a recent draft of ACTA. Chapter One, Section B of the agreement provides for “General Definitions.” It is interesting that the term “counterfeits” does not have a general definition. The ten defined terms include:

  • days
  • intellectual property (See below)
  • Council (ACTA Oversight Council)
  • measure
  • person (natural or juridical)
  • right owner (includes federation or assicaitons that have legal standing or authoirty to assert rights)
  • Continue Reading

Uncategorized

ACTA: the new institution

KEI has access to yet undisclosed sections of the negotiating ACTA text. The text is organized in 6 chapters. The longest is Chapter 2 on “legal framework for enforcement of intellectual property rights.” The second longest is Chapter 5, on “Institutional Arrangements.” In ten pages of text, the ACTA negotiators have set out a plan to create a new institution to administer, implement and modify ACTA. Continue Reading

Uncategorized

PhRMA’s asks regarding special 301, drug pricing and reimbursement

Below are asks from the 2010 PhRMA submission to the USTR Special 301 list on the topic of drug pricing and reimbursement decisions, and described as ‘Market Access Barriers.’ In its assertions, PhRMA attack countries for government price negotiations, making use of reference pricing, the insufficient involvement of pharmaceutical companies in setting government pricing policies and the composition of drug formularies, among other things.

CHINA

Continue Reading

Uncategorized